BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 37966260)

  • 1. Tumor Explants Elucidate a Cascade of Paracrine SHH, WNT, and VEGF Signals Driving Pancreatic Cancer Angiosuppression.
    Hasselluhn MC; Decker-Farrell AR; Vlahos L; Thomas DH; Curiel-Garcia A; Maurer HC; Wasko UN; Tomassoni L; Sastra SA; Palermo CF; Dalton TC; Ma A; Li F; Tolosa EJ; Hibshoosh H; Fernandez-Zapico ME; Muir A; Califano A; Olive KP
    Cancer Discov; 2024 Feb; 14(2):348-361. PubMed ID: 37966260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hedgehog signaling promotes angiogenesis directly and indirectly in pancreatic cancer.
    Bausch D; Fritz S; Bolm L; Wellner UF; Fernandez-Del-Castillo C; Warshaw AL; Thayer SP; Liss AS
    Angiogenesis; 2020 Aug; 23(3):479-492. PubMed ID: 32444947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of the stromal contribution to Sonic Hedgehog-dependent pancreatic adenocarcinoma.
    Damhofer H; Medema JP; Veenstra VL; Badea L; Popescu I; Roelink H; Bijlsma MF
    Mol Oncol; 2013 Dec; 7(6):1031-42. PubMed ID: 23998958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia activates the hedgehog signaling pathway in a ligand-independent manner by upregulation of Smo transcription in pancreatic cancer.
    Onishi H; Kai M; Odate S; Iwasaki H; Morifuji Y; Ogino T; Morisaki T; Nakashima Y; Katano M
    Cancer Sci; 2011 Jun; 102(6):1144-50. PubMed ID: 21338440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of amplified in breast cancer 1 contributes to pancreatic ductal adenocarcinoma progression and vulnerability to blockage of hedgehog activation.
    Li L; Bao J; Wang H; Lei JH; Peng C; Zeng J; Hao W; Zhang X; Xu X; Yu C; Deng CX; Chen Q
    Theranostics; 2021; 11(4):1672-1689. PubMed ID: 33408774
    [No Abstract]   [Full Text] [Related]  

  • 6. Hedgehog promotes neovascularization in pancreatic cancers by regulating Ang-1 and IGF-1 expression in bone-marrow derived pro-angiogenic cells.
    Nakamura K; Sasajima J; Mizukami Y; Sugiyama Y; Yamazaki M; Fujii R; Kawamoto T; Koizumi K; Sato K; Fujiya M; Sasaki K; Tanno S; Okumura T; Shimizu N; Kawabe J; Karasaki H; Kono T; Ii M; Bardeesy N; Chung DC; Kohgo Y
    PLoS One; 2010 Jan; 5(1):e8824. PubMed ID: 20098680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paracrine sonic hedgehog signaling derived from tumor epithelial cells: a key regulator in the pancreatic tumor microenvironment.
    Li X; Ma Q; Duan W; Liu H; Xu H; Wu E
    Crit Rev Eukaryot Gene Expr; 2012; 22(2):97-108. PubMed ID: 22856428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma.
    Rhim AD; Oberstein PE; Thomas DH; Mirek ET; Palermo CF; Sastra SA; Dekleva EN; Saunders T; Becerra CP; Tattersall IW; Westphalen CB; Kitajewski J; Fernandez-Barrena MG; Fernandez-Zapico ME; Iacobuzio-Donahue C; Olive KP; Stanger BZ
    Cancer Cell; 2014 Jun; 25(6):735-47. PubMed ID: 24856585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GLI1 is regulated through Smoothened-independent mechanisms in neoplastic pancreatic ducts and mediates PDAC cell survival and transformation.
    Nolan-Stevaux O; Lau J; Truitt ML; Chu GC; Hebrok M; Fernández-Zapico ME; Hanahan D
    Genes Dev; 2009 Jan; 23(1):24-36. PubMed ID: 19136624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRD4 promotes pancreatic ductal adenocarcinoma cell proliferation and enhances gemcitabine resistance.
    Wang YH; Sui YN; Yan K; Wang LS; Wang F; Zhou JH
    Oncol Rep; 2015 Apr; 33(4):1699-706. PubMed ID: 25647019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paracrine IL-6 signaling mediates the effects of pancreatic stellate cells on epithelial-mesenchymal transition via Stat3/Nrf2 pathway in pancreatic cancer cells.
    Wu YS; Chung I; Wong WF; Masamune A; Sim MS; Looi CY
    Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):296-306. PubMed ID: 27750041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galectin-1 drives pancreatic carcinogenesis through stroma remodeling and Hedgehog signaling activation.
    Martínez-Bosch N; Fernández-Barrena MG; Moreno M; Ortiz-Zapater E; Munné-Collado J; Iglesias M; André S; Gabius HJ; Hwang RF; Poirier F; Navas C; Guerra C; Fernández-Zapico ME; Navarro P
    Cancer Res; 2014 Jul; 74(13):3512-24. PubMed ID: 24812270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin 35 Expression Correlates With Microvessel Density in Pancreatic Ductal Adenocarcinoma, Recruits Monocytes, and Promotes Growth and Angiogenesis of Xenograft Tumors in Mice.
    Huang C; Li Z; Li N; Li Y; Chang A; Zhao T; Wang X; Wang H; Gao S; Yang S; Hao J; Ren H
    Gastroenterology; 2018 Feb; 154(3):675-688. PubMed ID: 28989066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SMAD4 loss triggers the phenotypic changes of pancreatic ductal adenocarcinoma cells.
    Chen YW; Hsiao PJ; Weng CC; Kuo KK; Kuo TL; Wu DC; Hung WC; Cheng KH
    BMC Cancer; 2014 Mar; 14():181. PubMed ID: 24625091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of angiotensin II type 2 receptor (AT2R) signaling in human pancreatic ductal adenocarcinoma (PDAC): a novel AT2R agonist effectively attenuates growth of PDAC grafts in mice.
    Ishiguro S; Yoshimura K; Tsunedomi R; Oka M; Takao S; Inui M; Kawabata A; Wall T; Magafa V; Cordopatis P; Tzakos AG; Tamura M
    Cancer Biol Ther; 2015; 16(2):307-16. PubMed ID: 25756513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the hedgehog pathway targets the tumor-associated stroma in pancreatic cancer.
    Hwang RF; Moore TT; Hattersley MM; Scarpitti M; Yang B; Devereaux E; Ramachandran V; Arumugam T; Ji B; Logsdon CD; Brown JL; Godin R
    Mol Cancer Res; 2012 Sep; 10(9):1147-57. PubMed ID: 22859707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sauchinone inhibits hypoxia-induced epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma cells through the Wnt/β-catenin pathway.
    Qiao Y; Yan LJ; Yan C
    Anticancer Drugs; 2020 Oct; 31(9):918-924. PubMed ID: 32889895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-tumor activity of cediranib, a pan-vascular endothelial growth factor receptor inhibitor, in pancreatic ductal adenocarcinoma cells.
    Momeny M; Alishahi Z; Eyvani H; Esmaeili F; Zaghal A; Ghaffari P; Tavakkoly-Bazzaz J; Alimoghaddam K; Ghavamzadeh A; Ghaffari SH
    Cell Oncol (Dordr); 2020 Feb; 43(1):81-93. PubMed ID: 31512195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elucidating the Role of miRNA-326 Modulating Hedgehog Signaling in Pancreatic Carcinoma.
    Rashid S; Rashid S; Das P; Malik N; Dash NR; Singh N; Pandey RM; Kumar L; Chauhan SS; Chosdol K; Gupta S; Saraya A
    Pancreas; 2024 Jan; 53(1):e42-e48. PubMed ID: 38019614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear factor-kappaB contributes to hedgehog signaling pathway activation through sonic hedgehog induction in pancreatic cancer.
    Nakashima H; Nakamura M; Yamaguchi H; Yamanaka N; Akiyoshi T; Koga K; Yamaguchi K; Tsuneyoshi M; Tanaka M; Katano M
    Cancer Res; 2006 Jul; 66(14):7041-9. PubMed ID: 16849549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.